Bohai Pharmaceuticals (BOPH) 10-K 2013 FY Annual report

Exhibit 21.1

Subsidiaries of the Registrant

1. The Company’s wholly owned subsidiary, Chance High International Limited, a British Virgin Islands company (“Chance High”);

2. Chance High’s wholly owned subsidiary, YantaiShencaojishi Pharmaceuticals Co., Ltd., a PRC company (“WOFE”);

3. Chance High’s wholly owned subsidiary, YantaiNirui Pharmaceutical Co., Ltd., a PRC company (“WOFE II”);

4. the WOFE’s variable interest entity, YantaiBohai Pharmaceuticals Group Co., Ltd., a PRC company (“Bohai”), which is the Company’s  initial operating subsidiary; and

5. WOFE II’s wholly owned subsidiary, Yantai Tianzheng Pharmaceutical Co., Ltd., a PRC company (“Yantai Tianzheng”), which the Company acquired in August 2011 and is the Company’s second operating subsidiary.